Cutaneous FUS::TFCP 2‐Rearranged Rhabdomyosarcoma Initially Misdiagnosed as ALK ‐Rearranged Mesenchymal Neoplasm: A Case Report
Journal of Cutaneous Pathology · 2025
DOI: 10.1111/cup.14869 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2025. Verfasst von Daigo Shiraishi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, RNA-Binding Protein FUS, Skin Neoplasms, Oncogene Proteins, Fusion. Die Arbeit nennt 12 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
FUS::TFCP 2‐rearranged rhabdomyosarcoma is a recently identified malignant neoplasm characterized by immunohistochemical evidence of the co‐expression of rhabdomyoblastic markers and ALK. Herein, we report a case of cutaneous spindle cell/sclerosing rhabdomyosarcoma with FUS::TFCP 2 fusion that was initially interpreted as an ALK‐rearranged mesenchymal neoplasm in a 43‐year‐old male due to negative desmin expression, a rhabdomyoblastic marker. RNA sequencing was performed to detect ALK fusion counterparts; however, no ALK counterpart fusion was observed, and FUS::TFCP 2 fusion was detected. Myogenin was negative, but MyoD1 was positive. Detection of FUS signals using FISH led to the diagnosis of FUS::TFCP 2‐rearranged rhabdomyosarcoma. In cases of ALK positivity and spindle cell or epithelioid cell morphology, FUS::TFCP 2‐rearranged rhabdomyosarcoma should be considered in the differential diagnosis using staining for rhabdomyoblastic markers other than desmin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
ORCID-Profile: Shintaro Sugita, Makoto Emori
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Shiraishi, D., Murata, K., Shimizu, J., Murahashi, Y., Sugawara, T., Sugita, S., Emori, M., & Teramoto, A. (2025). Cutaneous FUS::TFCP 2‐Rearranged Rhabdomyosarcoma Initially Misdiagnosed as ALK ‐Rearranged Mesenchymal Neoplasm: A Case Report. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14869
Vancouver
Shiraishi D, Murata K, Shimizu J, Murahashi Y, Sugawara T, Sugita S, et al. Cutaneous FUS::TFCP 2‐Rearranged Rhabdomyosarcoma Initially Misdiagnosed as ALK ‐Rearranged Mesenchymal Neoplasm: A Case Report. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14869
BibTeX
@article{Shiraishi2025,
author = {Shiraishi, Daigo and Murata, Kenji and Shimizu, Junya and Murahashi, Yasutaka and Sugawara, Taro and Sugita, Shintaro and Emori, Makoto and Teramoto, Atsushi},
title = {Cutaneous FUS::TFCP 2‐Rearranged Rhabdomyosarcoma Initially Misdiagnosed as ALK ‐Rearranged Mesenchymal Neoplasm: A Case Report},
journal = {Journal of Cutaneous Pathology},
year = {2025},
doi = {10.1111/cup.14869}
}
EUVIMED